Bvf Inc
Bvf Inc reported 44 holdings worth US$3.91B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Bvf Inc reported 44 holdings worth US$3.91B as of Jun 30, 2026. Largest: Revolution Medicines, Inc., Kymera Therapeutics, Inc. and Xoma Royalty Corporation. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 44
- Value as reported
- US$3.91B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Revolution Medicines, Inc. | 2.97M | US$555M | 14.2% |
| Kymera Therapeutics, Inc. | 3.87M | US$444M | 11.4% |
| Xoma Royalty Corporation | 7.59M | US$323M | 8.3% |
| Nektar Therapeutics | 2.39M | US$167M | 4.3% |
| Mirum Pharmaceuticals, Inc. | 1.06M | US$124M | 3.2% |
| Xencor, Inc. | 7.13M | US$115M | 2.9% |
| Monte Rosa Therapeutics, Inc. | 4.46M | US$108M | 2.8% |
| Cullinan Therapeutics, Inc. | 5.75M | US$105M | 2.7% |
| Palvella Therapeutics, Inc. | 673K | US$103M | 2.6% |
| Zymeworks Inc. | 3.65M | US$95.4M | 2.4% |
| Kura Oncology, Inc. | 8.45M | US$92.7M | 2.4% |
| Disc Medicine, Inc. | 1.15M | US$84.4M | 2.2% |
| Stoke Therapeutics, Inc. | 2.55M | US$83.4M | 2.1% |
| Olema Pharmaceuticals, Inc. | 5.3M | US$66.3M | 1.7% |
| Annexon, Inc. | 8.7M | US$49.7M | 1.3% |
| Crescent Biopharma, Inc. | 2.75M | US$49.5M | 1.3% |
| Tyra Biosciences, Inc. | 1.48M | US$47.1M | 1.2% |
| Sutro Biopharma, Inc. | 1.25M | US$41.6M | 1.1% |
| Avalo Therapeutics, Inc. | 2.08M | US$38.4M | 0.98% |
| 4d Molecular Therapeutics, Inc. | 2.88M | US$38.3M | 0.98% |
| Q32 Bio Inc. | 2.35M | US$29.9M | 0.77% |
| Anteris Technologies Global Corp. | 3M | US$29.6M | 0.76% |
| Foghorn Therapeutics Inc. | 5.84M | US$28.5M | 0.73% |
| Absci Corporation | 2.36M | US$27.4M | 0.70% |
| Eledon Pharmaceuticals, Inc. | 6.29M | US$24.8M | 0.63% |
| Invivyd, Inc. | 28.2M | US$24.6M | 0.63% |
| Sagimet Biosciences Inc. - Series A | 2.5M | US$19.3M | 0.49% |
| Onkure Therapeutics, Inc. | 3.24M | US$14.8M | 0.38% |
| Immunic, Inc. | 765K | US$11.8M | 0.30% |
| X4 Pharmaceuticals, Inc. | 2.23M | US$10.4M | 0.27% |
| Imagenebio, Inc. | 1.11M | US$6.55M | 0.17% |
| Tscan Therapeutics, Inc. | 5.56M | US$5.45M | 0.14% |
| Research Alliance Corporation Iii | 500K | US$5.35M | 0.14% |
| Molecular Partners Ag | 1.35M | US$5.15M | 0.13% |
| Tenax Therapeutics, Inc. | 340K | US$4.94M | 0.13% |
| Inventiva Sa | 686K | US$2.59M | 0.07% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Septerna, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related